16/03/2023

Vision, clarity and enabling – the drivers for Europe’s biomanufacturing future

EuropaBio is pleased to announce that Disc Medicine has joined as a corporate member.
07/03/2023

Disc Medicine joins EuropaBio: life-changing medicines for patients with hematologic disorders

EuropaBio is pleased to announce that Disc Medicine has joined as a corporate member.
06/03/2023

Can the Pharmaceutical Strategy Deliver for Europe?

03/03/2023

For The Love of Science

On the occasion of the International Day of Women and Girls in Science
01/03/2023

Vlad Olteanu new Healthcare Public Affairs Director at EuropaBio

28/02/2023

How do we live in a bioeconomy? EuropaBio at the Swedish EU Council Presidency conference

EuropaBio Industrial Biotechnology Director Agnes Borg took part in the Swedish EU Council Bioeconomy conference. She presented on the importance of food as a key part of the bioeconomy
28/02/2023

Helping Europe Deliver for Rare Disease Patients

24/02/2023

“Life is like a box of chocolates, you never know what you’ll get”

17/02/2023

Do your best and do not forget, there will always be a next time!

10/02/2023

Leave no pathway unexplored

06/02/2023

Delivering Europe’s ambitions in rare disease

13/12/2022

EuropaBio Principles for Genetic Testing and Testing for Genetically-Driven Risk Factor

European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers.
08/12/2022

‘Rare Disease Moonshot’ – Scaling-up public-private partnerships to accelerate research into world’s rarest diseases

European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers.
02/12/2022

EuropaBio’s 2022 Patient BioForum addresses the challenges of patients with unmet medical needs and calls for multi-stakeholder approach

European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers.
25/11/2022

The time to act is now! Biotechnology for global transformation

11/11/2022

The Revision of the Orphan Medicines Regulation Is an Opportunity. Will Europe Seize it?

24/10/2022

European Biotech Week 2022: Bringing Biotech to Local Communities

20/10/2022

Ensuring the full potential of EHDS: Stakeholders’ recommendations on how to make the digital transformation a success across Europe

19/10/2022

#EFIB2022:  Industrial biotechnology community comes together in Vilnius next week

06/10/2022

EuropaBio celebrates its inaugural Healthcare BioForum